AU530470B2 - Antihypertensive pyridazin (2h)-3-ones - Google Patents

Antihypertensive pyridazin (2h)-3-ones

Info

Publication number
AU530470B2
AU530470B2 AU55404/80A AU5540480A AU530470B2 AU 530470 B2 AU530470 B2 AU 530470B2 AU 55404/80 A AU55404/80 A AU 55404/80A AU 5540480 A AU5540480 A AU 5540480A AU 530470 B2 AU530470 B2 AU 530470B2
Authority
AU
Australia
Prior art keywords
pyridazin
antihypertensive
ones
antihypertensive pyridazin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU55404/80A
Other languages
English (en)
Other versions
AU5540480A (en
Inventor
Zaven S. Ariyan
Russell Buchman
Robert E. Moser
Larry J. Powers
William J. Pyne
James A. Scozzie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SDS Biotech Corp
Original Assignee
Diamond Shamrock Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diamond Shamrock Corp filed Critical Diamond Shamrock Corp
Publication of AU5540480A publication Critical patent/AU5540480A/en
Application granted granted Critical
Publication of AU530470B2 publication Critical patent/AU530470B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/18—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22—Nitrogen and oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU55404/80A 1979-02-12 1980-02-11 Antihypertensive pyridazin (2h)-3-ones Ceased AU530470B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US011416 1979-02-12
US06/011,416 US4238490A (en) 1979-02-12 1979-02-12 Antihypertensive pyridazin(2H)-3-ones

Publications (2)

Publication Number Publication Date
AU5540480A AU5540480A (en) 1980-08-21
AU530470B2 true AU530470B2 (en) 1983-07-14

Family

ID=21750288

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55404/80A Ceased AU530470B2 (en) 1979-02-12 1980-02-11 Antihypertensive pyridazin (2h)-3-ones

Country Status (11)

Country Link
US (1) US4238490A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0018063B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS55111473A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU530470B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1142920A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3062097D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK58680A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE49390B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL59356A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ192845A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA80776B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4545810A (en) * 1980-08-07 1985-10-08 Sds Biotech Corporation Herbicidal and plant growth regulant diphenylpyridazinones
WO1982000402A1 (en) * 1980-08-07 1982-02-18 Shamrock Corp Diamond Herbicidal and plant growth regulant diphenylpyridazinones
EP0088128A4 (en) * 1981-09-11 1984-04-06 Diamond Shamrock Corp ANTI-IGNITION AND ANALGETIC 4-PYRIDYLPYRIDAZINE (2H) -3-ONE.
FR2648135B1 (fr) * 1989-06-07 1991-09-27 Pf Medicament Derives de phenyl-1-dihydro-1,4 amino-3 oxo-4 pyridazines, leur preparation et leur application en therapeutique
US5189163A (en) * 1989-08-30 1993-02-23 Imperial Chemical Industries Plc Method of preparing pyridazinone derivatives
US4992439A (en) * 1990-02-13 1991-02-12 Bristol-Myers Squibb Company Pyridazine carboxylic acids and esters
TR200000478T2 (tr) * 1997-08-22 2002-04-22 Abbott Laboratories Prostaglandin endoperoksit H sentaz biyosentezi inhibitörleri olarak arilpiridazinonlar.
US6307047B1 (en) * 1997-08-22 2001-10-23 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
HUP0105248A3 (en) * 1998-10-27 2002-09-30 Abbott Lab Prostaglandin endoperoxide h synthase biosynthesis inhibitors pyridazinone-derivatives, pharmaceutical compositions containing them as active inaredient and process for preparation the compounds
JP2000247959A (ja) * 1999-02-26 2000-09-12 Kowa Co ピリダジン−３−オン誘導体及びこれを含有する医薬
JP2012503659A (ja) * 2008-09-24 2012-02-09 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 殺菌・殺カビ性ピリダジン

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE528490A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) *
US3900483A (en) * 1972-04-15 1975-08-19 Konishiroku Photo Ind ' -(2(1h)pyridone)+65 -pivalyl-5-(' -2,4-di-t-amyl-phenoxybutyramide)-acetanilides and derivatives

Also Published As

Publication number Publication date
IE49390B1 (en) 1985-10-02
EP0018063A1 (en) 1980-10-29
DK58680A (da) 1980-08-13
US4238490A (en) 1980-12-09
IE800253L (en) 1980-08-12
CA1142920A (en) 1983-03-15
NZ192845A (en) 1984-10-19
ZA80776B (en) 1981-02-25
DE3062097D1 (en) 1983-03-31
JPS55111473A (en) 1980-08-28
EP0018063B1 (en) 1983-02-23
AU5540480A (en) 1980-08-21
JPS6159626B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1986-12-17
IL59356A (en) 1984-05-31
IL59356A0 (en) 1980-05-30

Similar Documents

Publication Publication Date Title
AU572159B2 (en) 3(2h)-pyridazinone derivatives
AU530377B2 (en) Copper-nickel-silicon-chromium alloy
AU521589B2 (en) Antihypertensive aminoquinolines
AU520911B2 (en) Connection piece
AU520536B2 (en) Pyridazone compounds
GB2057438B (en) Pyridazinones
AU530470B2 (en) Antihypertensive pyridazin (2h)-3-ones
AU530840B2 (en) Combine
AU532424B2 (en) Antihypertensive agents
AU539238B2 (en) Substituted pyridazones
AU6868481A (en) Pyridazinone compounds
AU4260585A (en) 6-phenyl-5-methyl-4,5-dihydro-3(2h)-pyridazinone derivatives
AU549931B2 (en) Substituted pyridazines
AU531727B2 (en) Phthalazone derivatives
AU528558B2 (en) Transaminase determination
AU2191877A (en) Antihypertensive compositions
AU6324880A (en) Preparing hydrazines
AU511964B2 (en) Novel antihypertensive compositions
AU515368B2 (en) Antihypertensive compositions
AU2191977A (en) Antihypertensive compositions
AU563533B2 (en) Pyridazinone derivatives
AU8411682A (en) Antihypertensive compounds
JPS5634678A (en) Pyridazinone compound
AU532023B2 (en) 1(2h)-isoquinolone compounds
AU519673B2 (en) Antihypertensive quinazoline compounds